Literature DB >> 18458654

Hyperbilirubinemia diminishes respiratory drive in a rat pup model.

Oded Mesner1, Martha J Miller, Sabine C Iben, K C Prabha, Catherine A Mayer, Musa A Haxhiu, Richard J Martin.   

Abstract

Although apnea is common in premature babies, there is a paucity of information concerning the pathophysiologic basis of these episodes and their relationship to other perinatal conditions such as hyperbilirubinemia. Unconjugated hyperbilirubinemia in premature infants, even in moderately high levels, may cause encephalopathy affecting brainstem functions and has been linked to increased incidence of apnea in these infants. Thus, there is a need to clarify mechanisms by which bilirubin may alter respiratory control and induce apnea of prematurity. In this study, bilirubin or placebo was infused i.v. in 9-d-old rat pups (n = 36). Serum hyperbilirubinemia peaked in the first hours after bilirubin infusion. Twenty-four hours after bilirubin infusion, respiration was recorded by plethysmography at rest and under hypercapnic and hypoxic conditions. In treated pups, minute ventilation in room air was significantly reduced, hyperventilatory response to CO2 was blunted, and hypoxic ventilatory depression was increased, compared with placebo-injected rat pups. Brainstem bilirubin deposition and immunoreactivity to bilirubin was detected in the brainstem on histologic analysis. We speculate that high serum bilirubin levels may cause prolonged inhibition of brainstem autonomic function and that this could underlie the exacerbation of apnea noted in premature babies who have experienced jaundice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18458654      PMCID: PMC2574887          DOI: 10.1203/PDR.0b013e31817d9c0c

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  28 in total

Review 1.  Maturation of respiratory reflex responses in the fetus and neonate.

Authors:  Jalal M Abu-Shaweesh
Journal:  Semin Neonatol       Date:  2004-06

2.  What's in a name? Physiologic and pathologic jaundice: the conundrum of defining normal bilirubin levels in the newborn.

Authors:  M Jeffrey Maisels
Journal:  Pediatrics       Date:  2006-08       Impact factor: 7.124

3.  Rat cultured neuronal and glial cells respond differently to toxicity of unconjugated bilirubin.

Authors:  Rui F M Silva; Cecília M P Rodrigues; Dora Brites
Journal:  Pediatr Res       Date:  2002-04       Impact factor: 3.756

4.  Bilirubin induces apoptosis via the mitochondrial pathway in developing rat brain neurons.

Authors:  Cecília M P Rodrigues; Susana Solá; Dora Brites
Journal:  Hepatology       Date:  2002-05       Impact factor: 17.425

5.  Somatosensory and brainstem auditory evoked potentials in the Gunn rat model of acute bilirubin neurotoxicity.

Authors:  Steven M Shapiro
Journal:  Pediatr Res       Date:  2002-12       Impact factor: 3.756

Review 6.  Oxygen sensing by the carotid body chemoreceptors.

Authors:  N R Prabhakar
Journal:  J Appl Physiol (1985)       Date:  2000-06

7.  Cardiorespiratory events detected by home memory monitoring and one-year neurodevelopmental outcome.

Authors:  Carl E Hunt; Michael J Corwin; Terry Baird; Larry R Tinsley; Paula Palmer; Rangasamy Ramanathan; David H Crowell; Susan Schafer; Richard J Martin; David Hufford; Mark Peucker; Debra E Weese-Mayer; Jean M Silvestri; Michael R Neuman; Jean Cantey-Kiser
Journal:  J Pediatr       Date:  2004-10       Impact factor: 4.406

8.  Changes in globus pallidus with (pre)term kernicterus.

Authors:  Paul Govaert; Maarten Lequin; Renate Swarte; Simon Robben; René De Coo; Nynke Weisglas-Kuperus; Yolanda De Rijke; Maarten Sinaasappel; James Barkovich
Journal:  Pediatrics       Date:  2003-12       Impact factor: 7.124

Review 9.  Molecular basis of bilirubin-induced neurotoxicity.

Authors:  J Donald Ostrow; Lorella Pascolo; Dora Brites; Claudio Tiribelli
Journal:  Trends Mol Med       Date:  2004-02       Impact factor: 11.951

10.  Association between peak serum bilirubin and neurodevelopmental outcomes in extremely low birth weight infants.

Authors:  William Oh; Jon E Tyson; Avroy A Fanaroff; Betty R Vohr; Rebecca Perritt; Barbara J Stoll; Richard A Ehrenkranz; Waldemar A Carlo; Seetha Shankaran; Kenneth Poole; Linda L Wright
Journal:  Pediatrics       Date:  2003-10       Impact factor: 7.124

View more
  7 in total

Review 1.  Apnea in acute bilirubin encephalopathy.

Authors:  Sanjiv B Amin; Vinod K Bhutani; Jon F Watchko
Journal:  Semin Perinatol       Date:  2014-09-17       Impact factor: 3.300

2.  Operable malignant jaundice: To stent or not to stent before the operation?

Authors:  Rungsun Rerknimitr; Pinit Kullavanijaya
Journal:  World J Gastrointest Endosc       Date:  2010-01-16

3.  Unbound unconjugated hyperbilirubinemia is associated with central apnea in premature infants.

Authors:  Sanjiv B Amin; Hongyue Wang
Journal:  J Pediatr       Date:  2015-01-14       Impact factor: 4.406

Review 4.  Apnea of prematurity: from cause to treatment.

Authors:  Jing Zhao; Fernando Gonzalez; Dezhi Mu
Journal:  Eur J Pediatr       Date:  2011-02-08       Impact factor: 3.183

5.  Moderate Hyperbilirubinemia Alters Neonatal Cardiorespiratory Control and Induces Inflammation in the Nucleus Tractus Solitarius.

Authors:  Marie-Laure Specq; Mélisande Bourgoin-Heck; Nathalie Samson; François Corbin; Christian Gestreau; Maxime Richer; Hazim Kadhim; Jean-Paul Praud
Journal:  Front Physiol       Date:  2016-09-30       Impact factor: 4.566

6.  Plasma BNP level combined with surgical Apgar score to predict operative major cardiac adverse events in malignant obstructive jaundice patients.

Authors:  Wei Yu; Changshan Huang; Qian Wang; Erjiang Zhao; Yuechao Ding; Tao Huang; Chao Ma; Bo Meng
Journal:  Pak J Med Sci       Date:  2016 Sep-Oct       Impact factor: 1.088

7.  Auditory evoked potentials in a newborn Wistar rat model of hyperbilirubinemia.

Authors:  Çağıl Gökdoğan; Aydan Genç; Özlem Gülbahar; Ozan Gökdoğan; Ayşe Helvacı; Selin Üstün Bezgin; Leyla Memiş
Journal:  Braz J Otorhinolaryngol       Date:  2015-12-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.